Evidence map›Paper›PMID 23007461›Full record

ReviewPflugers Archiv : European journal of physiology2012

Molecular mechanisms of urea transport in health and disease.

Janet D Klein, Mitsi A Blount, Jeff M Sands

Abstract readReview
In one paragraph

Review in Pflugers Archiv : European journal of physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. SLC14A1 is a new biomarker in renal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  6. Review
  7. Inhibition of urea transporter ameliorates uremic cardiomyopathy in chronic kidney disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  8. Article
  9. Article
  10. Dialysis disequilibrium syndrome prevention and management.International journal of nephrology and renovascular disease · 2019
    Review
  11. Article
  12. Article
  13. SLC14A1: a novel target for human urothelial cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2017
    Review
  14. Treatment of cadmium-induced renal oxidative damage in rats by administration of alpha-lipoic acid.Environmental science and pollution research international · 2017
    Article
  15. Urea and Ammonia Metabolism and the Control of Renal Nitrogen Excretion.Clinical journal of the American Society of Nephrology : CJASN · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Thienoquinolins exert diuresis by strongly inhibiting UT-A urea transporters.American journal of physiology. Renal physiology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Janet D KleinRenal Division, Department of Medicine, and Department of Physiology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Mitsi A Blount
Jeff M Sands
Emory University · US

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Regulation of Renal Inner Medullary FunctionR01DK041707 · NIDDK · EMORY UNIVERSITY · PI SANDS, JEFF M · 1996 to 2017
$4.3M
Regulation of Urea Transport by PKC-alphaR01DK089828 · NIDDK · EMORY UNIVERSITY · PI SANDS, JEFF M · 2011 to 2014
$1.5M
Cyclic AMP Signaling Affects Urine Concentration through UT-A1K01DK082733 · NIDDK · EMORY UNIVERSITY · PI BLOUNT, MITSI A · 2008 to 2012
$742k
Novel Mouse Models for the Study of Urea TransportersR21DK091147 · NIDDK · EMORY UNIVERSITY · PI SANDS, JEFF M · 2011 to 2012
$233k
Phosphodiesterases in Lithium-Induced Nephrogenic Diabetes InsipidusR03DK091501 · NIDDK · EMORY UNIVERSITY · PI BLOUNT, MITSI A · 2011 to 2012
$155k
NCATS NIH HHS UL1 TR000454NIDDK NIH HHS K01 DK082733NIDDK NIH HHS K01-DK82733NIDDK NIH HHS R01 DK041707NIDDK NIH HHS R01 DK089828NIDDK NIH HHS R01 DK41707NIDDK NIH HHS R01-DK89828NIDDK NIH HHS R03 DK091501NIDDK NIH HHS R03-DK91501NIDDK NIH HHS R21 DK091147NIDDK NIH HHS R21-DK91147
6 · The paper itself

Abstract

In the late 1980s, urea permeability measurements produced values that could not be explained by paracellular transport or lipid phase diffusion. The existence of urea transport proteins were thus proposed and less than a decade later, the first urea transporter was cloned. The family of urea transporters has two major subgroups, designated SLC14A1 (or UT-B) and Slc14A2 (or UT-A). UT-B and UT-A gene products are glycoproteins located in various extra-renal tissues however, a majority of the resulting isoforms are found in the kidney. The UT-B (Slc14A1) urea transporter was originally isolated from erythrocytes and two isoforms have been reported. In kidney, UT-B is located primarily in the descending vasa recta. The UT-A (Slc14A2) urea transporter yields six distinct isoforms, of which three are found chiefly in the kidney medulla. UT-A1 and UT-A3 are found in the inner medullary collecting duct (IMCD), while UT-A2 is located in the thin descending limb. These transporters are crucial to the kidney's ability to concentrate urine. The regulation of urea transporter activity in the IMCD involves acute modification through phosphorylation and subsequent movement to the plasma membrane. UT-A1 and UT-A3 accumulate in the plasma membrane in response to stimulation by vasopressin or hypertonicity. Long-term regulation of the urea transporters in the IMCD involves altering protein abundance in response to changes in hydration status, low protein diets, or adrenal steroids. Urea transporters have been studied using animal models of disease including diabetes mellitus, lithium intoxication, hypertension, and nephrotoxic drug responses. Exciting new genetically engineered mouse models are being developed to study these transporters.

Indexed as

AnimalsBiological TransportHumansKidney Tubules, CollectingMembrane Transport ProteinsUreaUrea TransportersMembrane Transport ProteinsUreaUrea Transporters

Identifiers

PMID23007461
PMCPMC3514661
OpenAlexW2085143942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.